- Home
- CSTE vs BYSI Comparison
CSTE vs BYSI Comparison
Compare CSTE & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- BYSI
- Stock Information
- Founded
- CSTE 1987
- BYSI 2010
- Country
- CSTE Israel
- BYSI United States
- Employees
- CSTE N/A
- BYSI N/A
- Industry
- CSTE Building Materials
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- CSTE Industrials
- BYSI Health Care
- Exchange
- CSTE Nasdaq
- BYSI Nasdaq
- Market Cap
- CSTE 62.2M
- BYSI 71.0M
- IPO Year
- CSTE 2012
- BYSI 2017
- Fundamental
- Price
- CSTE $2.00
- BYSI $3.15
- Analyst Decision
- CSTE Strong Buy
- BYSI
- Analyst Count
- CSTE 1
- BYSI 0
- Target Price
- CSTE $6.00
- BYSI N/A
- AVG Volume (30 Days)
- CSTE 180.9K
- BYSI 81.2K
- Earning Date
- CSTE 08-06-2025
- BYSI 08-11-2025
- Dividend Yield
- CSTE N/A
- BYSI N/A
- EPS Growth
- CSTE N/A
- BYSI N/A
- EPS
- CSTE N/A
- BYSI N/A
- Revenue
- CSTE $424,487,000.00
- BYSI N/A
- Revenue This Year
- CSTE N/A
- BYSI N/A
- Revenue Next Year
- CSTE $6.60
- BYSI N/A
- P/E Ratio
- CSTE N/A
- BYSI N/A
- Revenue Growth
- CSTE N/A
- BYSI N/A
- 52 Week Low
- CSTE $1.62
- BYSI $0.98
- 52 Week High
- CSTE $6.54
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- CSTE 55.59
- BYSI 72.10
- Support Level
- CSTE $1.62
- BYSI $2.73
- Resistance Level
- CSTE $1.93
- BYSI $3.44
- Average True Range (ATR)
- CSTE 0.14
- BYSI 0.33
- MACD
- CSTE 0.06
- BYSI 0.12
- Stochastic Oscillator
- CSTE 100.00
- BYSI 81.49
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.